Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1957 1
1997 1
2001 1
2003 3
2005 3
2006 2
2007 1
2008 7
2009 3
2010 3
2011 5
2012 5
2013 7
2014 5
2015 14
2016 20
2017 26
2018 18
2019 20
2020 13
2021 18
2022 11
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 26048266

170 results

Results by year

Filters applied: . Clear all
Page 1
Off-Label Uses of Omalizumab.
El-Qutob D. El-Qutob D. Clin Rev Allergy Immunol. 2016 Feb;50(1):84-96. doi: 10.1007/s12016-015-8490-y. Clin Rev Allergy Immunol. 2016. PMID: 26048266 Review.
IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
Navinés-Ferrer A, Serrano-Candelas E, Molina-Molina GJ, Martín M. Navinés-Ferrer A, et al. J Immunol Res. 2016;2016:8163803. doi: 10.1155/2016/8163803. Epub 2016 Dec 21. J Immunol Res. 2016. PMID: 28097159 Free PMC article. Review.
Omalizumab, an anti-immunoglobulin E antibody: state of the art.
Incorvaia C, Mauro M, Russello M, Formigoni C, Riario-Sforza GG, Ridolo E. Incorvaia C, et al. Drug Des Devel Ther. 2014 Feb 7;8:197-207. doi: 10.2147/DDDT.S49409. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 24532966 Free PMC article.
The use of anti-IgE therapy beyond allergic asthma.
Stokes JR, Casale TB. Stokes JR, et al. J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):162-6. doi: 10.1016/j.jaip.2014.10.010. Epub 2015 Jan 16. J Allergy Clin Immunol Pract. 2015. PMID: 25609342 Review.
Omalizumab in children with severe allergic disease: a case series.
Crisafulli G, Caminiti L, Chiera F, Arasi S, Salzano G, Panasiti I, Barbalace A, Pajno GB. Crisafulli G, et al. Ital J Pediatr. 2019 Jan 14;45(1):13. doi: 10.1186/s13052-019-0602-5. Ital J Pediatr. 2019. PMID: 30642367 Free PMC article.
Anti-IgE--emerging opportunities for Omalizumab.
Babu KS, Polosa R, Morjaria JB. Babu KS, et al. Expert Opin Biol Ther. 2013 May;13(5):765-77. doi: 10.1517/14712598.2013.782391. Epub 2013 Mar 22. Expert Opin Biol Ther. 2013. PMID: 23517576 Review.
Effects of omalizumab in patients with food allergy.
Rafi A, Do LT, Katz R, Sheinkopf LE, Simons CW, Klaustermeyer W. Rafi A, et al. Allergy Asthma Proc. 2010 Jan-Feb;31(1):76-83. doi: 10.2500/aap.2010.31.3304. Allergy Asthma Proc. 2010. PMID: 20167148 Clinical Trial.
The use of omalizumab in allergen immunotherapy.
Dantzer JA, Wood RA. Dantzer JA, et al. Clin Exp Allergy. 2018 Mar;48(3):232-240. doi: 10.1111/cea.13084. Epub 2018 Jan 30. Clin Exp Allergy. 2018. PMID: 29315922 Review.
Dermatologic uses of omalizumabtitle.
Chia JC, Mydlarski PR. Chia JC, et al. J Dermatolog Treat. 2017 Jun;28(4):332-337. doi: 10.1080/09546634.2016.1249819. Epub 2016 Nov 7. J Dermatolog Treat. 2017. PMID: 27759482 Review.
170 results